| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8932718 | British Journal of Anaesthesia | 2014 | 10 Pages | 
Abstract
												Antifibrinolytics and COX inhibitors can affect the proteolytic profile of the tumour microenvironment. Animal and clinical investigations are warranted to assess the effect of these proteolytic changes on the outcome of cancer surgery.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Anesthesiology and Pain Medicine
												
											Authors
												B. Afsharimani, P.J. Cabot, M.-O. Parat, 
											